CN100998831A - Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney - Google Patents

Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney Download PDF

Info

Publication number
CN100998831A
CN100998831A CN 200610130861 CN200610130861A CN100998831A CN 100998831 A CN100998831 A CN 100998831A CN 200610130861 CN200610130861 CN 200610130861 CN 200610130861 A CN200610130861 A CN 200610130861A CN 100998831 A CN100998831 A CN 100998831A
Authority
CN
China
Prior art keywords
radix
medicine
gram
chinese medicine
cerebral arteriosclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200610130861
Other languages
Chinese (zh)
Inventor
江蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200610130861 priority Critical patent/CN100998831A/en
Publication of CN100998831A publication Critical patent/CN100998831A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

An interior-applied Chinese medicine for treating the qi deficiency cerebral arteriosclerosis is prepared from 13 Chinese-medicinal materials including red sage root, wolfberry fruit, fleece flower root, ganoderma, etc.

Description

A kind of Chinese medicine for oral administration for the treatment of QI deficiency type cerebral arteriosclerosis
Technical field:
The present invention relates to field of Chinese herbal, especially relate to and prevent and treat the very good a kind of Chinese medicine for oral administration for the treatment of QI deficiency type cerebral arteriosclerosis of QI deficiency type cerebral arteriosclerosis effect.
Background technology:
Cerebral arteriosclerosis is that cerebrovascular chronic hyperplastic changes, and pathological changes is comparatively extensive.Its basic feature is dizzy, dizzy, headache, and memory obviously goes down, and upper limb often has feeling of numbness, insomnia and dreamful sleep, red tongue with thin fur, thready and stringy pulse; Rheoencephalogram shows that cerebral blood vessel elasticity goes down, blood supply insufficiency, drug test prompting cerebral arteriosclerosis; Examination of ocular fundus retinal arteriosclerosis etc.The symptom of QI deficiency type cerebral arteriosclerosis shows as: except that the basic feature of cerebral arteriosclerosis, the companion sees lassitude and weak, and the tone is humble, and is moving then pant spontaneous perspiration etc.The reason that causes this disease mainly is due to the deficiency of vital energy, the deficiency of kidney-YIN.At present, the method for the treatment of QI deficiency type cerebral arteriosclerosis both at home and abroad is more, and as the western medical treatment method, medicine commonly used has lovastatin, pravastatin, flunarizine etc.; As the treatment by Chinese herbs method, medicine commonly used has GUIPI WAN, LIUWEI DIHUANG WAN etc.But, be difficult to the effect that reaches satisfied at aspects such as cure rate, treatment means, medical expenses.
Find no the prescription identical by retrieval with the present invention.
Summary of the invention:
The Therapeutic Method that the present invention adopts is the herbal decoction therapy.
The objective of the invention is to overcome the weak point on the treatment QI deficiency type cerebral arteriosclerosis at present, and a kind of herbal decoction medicine and preparation method of the treatment QI deficiency type cerebral arteriosclerosis easy, easy to prepare, that expense is cheap and cure rate is higher of drawing materials are provided.
Technical scheme of the present invention is achieved in that
A kind of Chinese medicine for oral administration for the treatment of QI deficiency type cerebral arteriosclerosis, its medicine is to be made by the raw material of following weight parts: Radix Salviae Miltiorrhizae 15-18 gram, the Radix Astragali, each 13-15 gram of Radix Codonopsis, Fructus Lycii, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati Odorati, Ganoderma, Rhizoma Acori Graminei, Fructus Crataegi, Rhizoma Alismatis, Radix Paeoniae Rubra, each 10-12 gram of Radix Curcumae, Flos Chrysanthemi 6-7 gram.
A kind of Chinese medicine for oral administration for the treatment of QI deficiency type cerebral arteriosclerosis, the preparation method of its medicine is: earlier Chinese herbal medicine such as proportional quantity Radix Salviae Miltiorrhizae, the Radix Astragali, Radix Codonopsis, Fructus Lycii, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati Odorati, Ganoderma, Rhizoma Acori Graminei, Fructus Crataegi, Rhizoma Alismatis, Radix Paeoniae Rubra, Radix Curcumae, Flos Chrysanthemi are put into the utensil of boiling medicine, add the clean water that meets drinking water standard, amount of water is to surpass powder 2-3cm degree of being.Before going into to fry in shallow oil said herbal medicine is soaked half an hour, make it fully moistening, fully fried in order to medicine juice.Then, (suddenly) fire of useing force boils to be used literary composition (little) fire again instead and decocts.Stop when decocting about 15 minutes, remove medicinal residues, get decoction.
In the Chinese medicine for oral administration of the present invention: Radix Salviae Miltiorrhizae has promoting tissue regeneration by removing blood stasis, promoting blood flow to regulate menstruation effect; The Radix Astragali has benefit and defends consolidating superficial resistance, inducing diuresis to remove edema effect; Radix Codonopsis has invigorating the spleen and replenishing QI, the spleen and stomach regulating effect; Fructus Lycii has YIN nourishing, invigorating the liver and kidney effect; Radix Polygoni Multiflori Preparata has invigorating the liver and kidney, benefiting essence-blood effect; Rhizoma Polygonati Odorati has the nourishing YIN to relieve dryness effect; Ganoderma has the strengthening by means of tonics effect; Rhizoma Acori Graminei have allay excitement have one's ideas straightened out, the warming middle-JIAO for easing the stomach effect; Fructus Crataegi has promoting digestion and invigorating the stomach, the effect of invigorating blood circulation; Rhizoma Alismatis has the diuresis eliminating dampness by diuresis, rushes down the scorching posthumous work usefulness of ending; Radix Paeoniae Rubra has the promoting blood circulation to remove blood stasis effect; Radix Curcumae has promoting QI circulation for relieving depression, the effect of pain relieving removing blood stasis with potent drugs; Flos Chrysanthemi has wind and heat dispersing, suppressing the hyperactive liver function of improving eyesight.Said herbal medicine is through organic assembling, dialectical compatibility and assist a ruler in governing a country mutually, has strengthened the effect of this medicine invigorating the spleen and replenishing QI, replenishing YIN to strengthen the kidney, thereby has reached the purpose of curing QI deficiency type cerebral arteriosclerosis.
Use the Chinese medicine for oral administration treatment QI deficiency type cerebral arteriosclerosis of treatment QI deficiency type cerebral arteriosclerosis of the present invention that following characteristics are arranged: draw materials easy, easy to prepare, expense is cheap, instant effect.
Instructions of taking:
1, dose: every day potion.With head fry in shallow oil, two fry in shallow oil the decoction fried in shallow oil for twice and mix after, take at twice.
2, medicine time: the upper and lower noon respectively once took medicine after the meal in two hours.
3, medicine temperature control: decoction being taken warmly.
The taboo item:
Treatment, fried sticky, the cold solid food hard, nondigestible and excitatory of period in a medicine taboo edible oil.
The specific embodiment:
Embodiment 1: a kind of composition of raw materials for the treatment of the Chinese medicine for oral administration of QI deficiency type cerebral arteriosclerosis: Radix Salviae Miltiorrhizae 15 grams, the Radix Astragali, each 13 gram of Radix Codonopsis, Fructus Lycii, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati Odorati, Ganoderma, Rhizoma Acori Graminei, Fructus Crataegi, Rhizoma Alismatis, Radix Paeoniae Rubra, each 10 gram of Radix Curcumae, Flos Chrysanthemi 6 grams.The preparation method of medicine is: earlier Chinese herbal medicine such as proportional quantity Radix Salviae Miltiorrhizae, the Radix Astragali, Radix Codonopsis, Fructus Lycii, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati Odorati, Ganoderma, Rhizoma Acori Graminei, Fructus Crataegi, Rhizoma Alismatis, Radix Paeoniae Rubra, Radix Curcumae, Flos Chrysanthemi are put into the utensil of boiling medicine, add the clean water that meets drinking water standard, amount of water is to surpass powder 2-3cm degree of being.Before going into to fry in shallow oil said herbal medicine is soaked half an hour, make it fully moistening, fully fried in order to medicine juice.Then, (suddenly) fire of useing force boils to be used literary composition (little) fire again instead and decocts.Stop when decocting about 15 minutes, remove medicinal residues, get decoction.
Embodiment 2: a kind of composition of raw materials for the treatment of the Chinese medicine for oral administration of QI deficiency type cerebral arteriosclerosis: Radix Salviae Miltiorrhizae 18 grams, the Radix Astragali, each 15 gram of Radix Codonopsis, Fructus Lycii, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati Odorati, Ganoderma, Rhizoma Acori Graminei, Fructus Crataegi, Rhizoma Alismatis, Radix Paeoniae Rubra, each 12 gram of Radix Curcumae, Flos Chrysanthemi 7 grams.The preparation method of medicine is: earlier Chinese herbal medicine such as proportional quantity Radix Salviae Miltiorrhizae, the Radix Astragali, Radix Codonopsis, Fructus Lycii, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati Odorati, Ganoderma, Rhizoma Acori Graminei, Fructus Crataegi, Rhizoma Alismatis, Radix Paeoniae Rubra, Radix Curcumae, Flos Chrysanthemi are put into the utensil of boiling medicine, add the clean water that meets drinking water standard, amount of water is to surpass powder 2-3cm degree of being.Before going into to fry in shallow oil said herbal medicine is soaked half an hour, make it fully moistening, fully fried in order to medicine juice.Then, (suddenly) fire of useing force boils to be used literary composition (little) fire again instead and decocts.Stop when decocting about 15 minutes, remove medicinal residues, get decoction.
Therapeutic effect:
Criterion of therapeutical effect: a kind of curative effect for the treatment of the Chinese medicine for oral administration treatment QI deficiency type cerebral arteriosclerosis of QI deficiency type cerebral arteriosclerosis judges whether mainly be dependent on the QI deficiency type cerebral arteriosclerosis symptom disappears.Taking medicine 40 days is 1 course of treatment.Concrete curative effect is divided following three grades: cure---and the QI deficiency type cerebral arteriosclerosis symptom all disappears, and rheoencephalogram, examination of ocular fundus are normal; Taking a turn for the better---the QI deficiency type cerebral arteriosclerosis symptom partly disappears and alleviates, and rheoencephalogram and examination of ocular fundus have improvement; Invalid---after 1 course of treatment of taking medicine, the QI deficiency type cerebral arteriosclerosis symptom has no to disappear.
Effect: with these Drug therapy QI deficiency type cerebral arteriosclerosis patient 19 examples, treat 1 course of treatment, wherein cure 16 examples, 3 examples that take a turn for the better, cure rate is 84%, effective percentage is 100%.
Model case:
Lee so-and-so, man, 67 years old, retired professor.Go to a doctor in June, 2005.Patient's readme is normal sense lassitude and weak over nearly 1 year, and is moving then pant spontaneous perspiration, dizziness headache, hypomnesis.The indagation rheoencephalogram shows that cerebral blood vessel elasticity goes down the examination of ocular fundus retinal arteriosclerosis.Be diagnosed as QI deficiency type cerebral arteriosclerosis.Adopt Chinese medicine for oral administration of the present invention, clothes are 20 doses earlier, and symptom is clearly better, 20 doses of continuous clothes, and symptom all disappears.Visit after 1 year, do not see recurrence.

Claims (1)

1, a kind of Chinese medicine for oral administration for the treatment of QI deficiency type cerebral arteriosclerosis, it is characterized in that this medicine is to be made by the raw material of following weight parts: Radix Salviae Miltiorrhizae 15-18 gram, the Radix Astragali, each 13-15 gram of Radix Codonopsis, Fructus Lycii, Radix Polygoni Multiflori Preparata, Rhizoma Polygonati Odorati, Ganoderma, Rhizoma Acori Graminei, Fructus Crataegi, Rhizoma Alismatis, Radix Paeoniae Rubra, each 10-12 gram of Radix Curcumae, Flos Chrysanthemi 6-7 gram.
CN 200610130861 2006-12-28 2006-12-28 Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney Pending CN100998831A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200610130861 CN100998831A (en) 2006-12-28 2006-12-28 Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200610130861 CN100998831A (en) 2006-12-28 2006-12-28 Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney

Publications (1)

Publication Number Publication Date
CN100998831A true CN100998831A (en) 2007-07-18

Family

ID=38257704

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200610130861 Pending CN100998831A (en) 2006-12-28 2006-12-28 Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney

Country Status (1)

Country Link
CN (1) CN100998831A (en)

Similar Documents

Publication Publication Date Title
CN101095741B (en) Chinese traditional medicine for oral administration for treating senile constipation
CN101204497A (en) Peroral Chinese traditional medicine for aplastic anemia
CN100998664A (en) Oral traditional Chinese medicine for treating critical anhypnia of insulfficiency of the spleen-qi type
CN100998722B (en) Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia
CN101439170A (en) Chinese medicine prescription for treating ulcerative colitis
CN1923272A (en) Decoction medicine for treating chest sweat syndrome with deficiency of qi and blood in the heart and spleen and its preparation method
CN100998825A (en) Oral Chinese medicine for treating yin blood insufficiency type virus myocarditis
CN100998682A (en) Oral traditional Chinese medicine for treating serious hyposomnia of qi-blood disharmony type
CN100998833A (en) Oral Chinese medicine for treating brain arteriosclerosis due to hyperactivity of liver-yang
CN101028430A (en) Oral Chinese medicine for treating Yang-deficiency rheumatic heart disease
CN100998829A (en) Oral administration Chinese medicine for treating brain arteriosclerosis
CN101028415A (en) Oral Chinese medicine for treating phlegm-heat obstructive rheumatic heart disease
CN100542565C (en) A kind of Chinese medicine for oral administration for the treatment of cephalagra type hemihidrosis disease
CN100998728A (en) Oral traditional Chinese medicine for treating astriction of insufficiency of yang type
CN100998818B (en) Oral Chinese medicine for treating damp-heat impairment of yang night sweating
CN100998684A (en) Oval traditional Chinese medicine for treating hypopiesi of heart-spleen deficiency type
CN100998832A (en) Orally taken Chinese medicine for treating action disturbance brain arteriosclerosis
CN100998720B (en) Oral traditional Chinese medicine for treating amenorrhea of uterus stasis
CN100998817A (en) Orally taken Chinese medicine for treating constitutional hypotension
CN101002914B (en) Chinese oral medicine for treating deficiency of vital energy type chilblain
CN100998750A (en) Oral traditional Chinese medicine for treating viral myocarditis of yin deficiency and blood stasis type
CN100998831A (en) Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney
CN101002925A (en) Chinese oral medicine for treating vomiting and regurgitation type rheumatic heart disease
CN101002889A (en) Oral traditional Chinese medicine for treating bitter taste type hypertension
CN100998830A (en) Orally taken Chinese medicine for treating phlegm turbitity type brain arteriosclerosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070718